[go: up one dir, main page]

DK141891D0 - Fremgangsmaade til fremstilling af partikler med v edvarende frigivelse af aktiv ingrediens og partikler fremstillet herved - Google Patents

Fremgangsmaade til fremstilling af partikler med v edvarende frigivelse af aktiv ingrediens og partikler fremstillet herved

Info

Publication number
DK141891D0
DK141891D0 DK911418A DK141891A DK141891D0 DK 141891 D0 DK141891 D0 DK 141891D0 DK 911418 A DK911418 A DK 911418A DK 141891 A DK141891 A DK 141891A DK 141891 D0 DK141891 D0 DK 141891D0
Authority
DK
Denmark
Prior art keywords
particles
procedure
active ingredients
current release
manufacturing
Prior art date
Application number
DK911418A
Other languages
English (en)
Other versions
DK175756B1 (da
DK141891A (da
Inventor
Jean-Marc Ruiz
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of DK141891D0 publication Critical patent/DK141891D0/da
Publication of DK141891A publication Critical patent/DK141891A/da
Application granted granted Critical
Publication of DK175756B1 publication Critical patent/DK175756B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Glanulating (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK199101418A 1990-08-01 1991-07-31 Fremgangsmåde til fremstilling af partikler med vedvarende frigivelse af aktiv ingrediens og partikler fremstillet herved DK175756B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions
GB9016885 1990-08-01

Publications (3)

Publication Number Publication Date
DK141891D0 true DK141891D0 (da) 1991-07-31
DK141891A DK141891A (da) 1992-02-02
DK175756B1 DK175756B1 (da) 2005-02-14

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199101418A DK175756B1 (da) 1990-08-01 1991-07-31 Fremgangsmåde til fremstilling af partikler med vedvarende frigivelse af aktiv ingrediens og partikler fremstillet herved

Country Status (30)

Country Link
US (1) US5213812A (da)
JP (1) JP2818704B2 (da)
KR (1) KR920003962A (da)
AT (1) AT396425B (da)
AU (2) AU649696B2 (da)
BE (1) BE1004772A3 (da)
CA (1) CA2048270C (da)
CH (1) CH682715A5 (da)
DE (1) DE4125542A1 (da)
DK (1) DK175756B1 (da)
ES (1) ES2046083B1 (da)
FI (1) FI104149B (da)
FR (1) FR2665360B1 (da)
GB (1) GB9016885D0 (da)
GR (1) GR1001512B (da)
HK (1) HK33294A (da)
IE (1) IE65124B1 (da)
IN (1) IN178446B (da)
IT (1) IT1251788B (da)
LU (1) LU87982A1 (da)
MA (1) MA22245A1 (da)
MY (1) MY107500A (da)
NL (1) NL194637C (da)
NO (1) NO300158B1 (da)
NZ (1) NZ238981A (da)
OA (1) OA09387A (da)
PT (1) PT98497B (da)
SE (1) SE505734C2 (da)
TN (1) TNSN91067A1 (da)
ZA (1) ZA915565B (da)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
DE69529054T2 (de) * 1994-02-28 2003-08-21 Nanopharm Ag System zur gezielten wirkstoffzufuhr, verfahren zu seiner herstellung und verwendung
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
AU4571097A (en) * 1996-10-09 1998-05-05 Takeda Chemical Industries Ltd. A method for producing a microparticle
TW577759B (en) * 1997-04-18 2004-03-01 Ipsen Pharma Biotech Sustained release compositions in the form of microcapsules or implants and the process for their preparation
EP1079967A4 (en) 1998-04-13 2003-07-23 Luminex Corp LIQUID MARKING USING FLUORESCENT MICROPARTICLES
MEP19408A (en) * 1998-12-16 2010-06-10 Aventis Pharma Inc Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US7374782B2 (en) 2000-10-27 2008-05-20 Baxter International Inc. Production of microspheres
US20050233945A1 (en) * 2003-07-18 2005-10-20 Larry Brown Methods for fabrication, uses and compositions of small spherical particles of insulin prepared by controlled phase separation
DE60226613D1 (de) * 2001-08-16 2008-06-26 Baxter Int Darreichungsformen welche mikropartikel und treibgas enthalten
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
CA2532874A1 (en) * 2003-07-22 2005-02-03 Baxter International Inc. Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
EP1765294B1 (en) * 2004-05-12 2008-09-24 Baxter International Inc. Nucleic acid microspheres, production and delivery thereof
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
WO2005112893A1 (en) * 2004-05-12 2005-12-01 Baxter International Inc. Microspheres comprising protein and showing injectability at high concentrations of said agent
WO2005112885A2 (en) * 2004-05-12 2005-12-01 Baxter International Inc. Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
JP2008506699A (ja) * 2004-07-13 2008-03-06 アルテアーナノ，インコーポレーテッド 薬物転用防止用セラミック構造体
KR20070042177A (ko) * 2004-07-13 2007-04-20 알타이어나노 인코포레이티드 약물의 조절 방출을 위한 세라믹 구조체
JP2008528443A (ja) * 2004-10-29 2008-07-31 アドヒーシブズ・リサーチ・インコーポレイテッド セキュリティ・アイデンティフィケーションのための微視的なタグ付けシステム
EP1885335A1 (en) * 2005-04-27 2008-02-13 BAXTER INTERNATIONAL INC. (a Delaware corporation) Surface-modified microparticles and methods of forming and using the same
AU2006283170A1 (en) * 2005-08-23 2007-03-01 Altairnano, Inc. Highly photocatalytic phosphorus-doped anatase-TiO2 composition and related manufacturing methods
WO2007103812A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Method for low temperature production of nano-structured iron oxide coatings
US20080020175A1 (en) * 2006-03-02 2008-01-24 Fred Ratel Nanostructured Indium-Doped Iron Oxide
WO2007103824A1 (en) * 2006-03-02 2007-09-13 Altairnano, Inc. Nanostructured metal oxides
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
AU2007281737B2 (en) 2006-08-04 2013-09-19 Baxter Healthcare S.A. Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
CA2663589A1 (en) * 2006-10-06 2008-05-22 Baxter International Inc. Microencapsules containing surface-modified microparticles and methods of forming and using the same
CA2702340C (en) 2006-10-12 2014-12-16 The University Of Queensland Compositions and methods for modulating immune responses
US20090169628A1 (en) * 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
US20080254258A1 (en) * 2007-04-12 2008-10-16 Altairnano, Inc. Teflon® replacements and related production methods
US8808747B2 (en) * 2007-04-17 2014-08-19 Baxter International Inc. Nucleic acid microparticles for pulmonary delivery
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
ES2686708T3 (es) 2008-04-18 2018-10-19 Baxter International Inc. Composición basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nueva aparición
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
WO2010037021A2 (en) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Spinneret and method of spinning fiber
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010132763A1 (en) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fiber having non-uniform composition and method for making same
MX357630B (es) 2009-05-27 2018-07-17 Selecta Biosciences Inc Nanoportadores sintéticos objetivo con liberación sensible al ph de agentes inmunomoduladores.
US20110076771A1 (en) * 2009-09-25 2011-03-31 Armark Authentication Technologies, Llc Tissue fiber scaffold and method for making
EA030813B1 (ru) 2010-05-26 2018-10-31 Селекта Байосайенсиз, Инк Способы генерации антительного иммунного ответа и увеличения местной индукции иммунных цитокинов при использовании синтетических наноносителей, соединенных с адъювантами
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
JP2013545453A (ja) 2010-11-01 2013-12-26 ユニバーシティ・オブ・テクノロジー、シドニー 免疫変調剤およびそれらの使用
WO2013019648A1 (en) 2011-07-29 2013-02-07 Selecta Biosciences, Inc. Control of antibody responses to synthetic nanocarriers
US10695406B2 (en) 2014-05-27 2020-06-30 The University Of Queensland Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (da) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
EP0366058A3 (en) * 1988-10-27 1991-03-20 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device

Also Published As

Publication number Publication date
FI104149B1 (fi) 1999-11-30
HK33294A (en) 1994-04-22
MA22245A1 (fr) 1992-04-01
IE65124B1 (en) 1995-10-04
GR1001512B (el) 1994-02-28
DE4125542A1 (de) 1992-02-06
ATA152591A (de) 1993-01-15
DK175756B1 (da) 2005-02-14
IN178446B (da) 1997-05-03
SE505734C2 (sv) 1997-10-06
GR910100330A (en) 1992-08-31
NO300158B1 (no) 1997-04-21
AU5939394A (en) 1994-06-02
PT98497A (pt) 1992-06-30
AU8146691A (en) 1992-02-06
FI913646L (fi) 1992-02-02
US5213812A (en) 1993-05-25
IT1251788B (it) 1995-05-26
AT396425B (de) 1993-09-27
DK141891A (da) 1992-02-02
CA2048270C (en) 1997-02-25
CH682715A5 (fr) 1993-11-15
SE9102249D0 (sv) 1991-07-26
NL9101306A (nl) 1992-03-02
MY107500A (en) 1995-12-30
NZ238981A (en) 1992-11-25
BE1004772A3 (fr) 1993-01-26
LU87982A1 (fr) 1992-04-15
FI913646A0 (fi) 1991-07-31
FI104149B (fi) 1999-11-30
ES2046083A1 (es) 1994-01-16
JPH05178740A (ja) 1993-07-20
NO912986D0 (no) 1991-07-31
ITMI911953A1 (it) 1993-01-15
TNSN91067A1 (fr) 1992-10-25
ITMI911953A0 (it) 1991-07-15
PT98497B (pt) 1997-10-31
FR2665360A1 (fr) 1992-02-07
AU649696B2 (en) 1994-06-02
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
AU666808B2 (en) 1996-02-22
IE912700A1 (en) 1992-02-12
KR920003962A (ko) 1992-03-27
FR2665360B1 (fr) 1995-02-10
SE9102249L (sv) 1992-02-02
GB9016885D0 (en) 1990-09-12
CA2048270A1 (en) 1992-02-02
JP2818704B2 (ja) 1998-10-30
ZA915565B (en) 1992-04-29
OA09387A (fr) 1992-09-15
NL194637C (nl) 2002-10-04
ES2046083B1 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
DK141891D0 (da) Fremgangsmaade til fremstilling af partikler med v edvarende frigivelse af aktiv ingrediens og partikler fremstillet herved
DK178285A (da) Catecholamin-holdig intranasal laegemiddelformulering med forsinket frigivelse af den aktive bestanddel
DK98088A (da) Farmaceutisk formulering med forsinket frigivelse af den aktive bestanddel
DK155415C (da) Fremgangsmaade til fremstilling af tygge- og bideben
MX9100031A (es) Compuestos de amino silicona y procedimiento para su preparacion
MX9101793A (es) Derivados de tiazolidindiona y procedimiento para su preparacion
NO873993D0 (no) Fremgangsmaate for fremstilling av fluorid- og calsiumpreparat med langvarig frigivelse.
DK397388A (da) Derivater af n-aminobutyl-n-phenylarylamider til terapeutisk anvendelse samt fremgangsmaade til fremstilling af saadanne derivater
NO830238L (no) Fremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer
DK100289A (da) Fremgangsmaade til fremstilling af n-sulfonylurinstoffer
MX9100811A (es) Indolonaftiridinas y procedimiento para su preparacion
MX9100388A (es) Derivados de carboximetilciclopropano y procedimiento para su preparacion
DE69518193D1 (de) Präparat mit verzörgerter Wirkstoffabgabe
IL97288A0 (en) Photosensitive formulations containing carbodiimide derivatives and processes for the preparation thereof
DK199984D0 (da) Benzoyl-urinstof-derivater med insekticid-virkning og fremgangsmaade til fremstilling af saadanne derivater
DK73980A (da) Insecticidt eller nematodicidt granulat med forhalet frigoerelse af den aktive bestanddel
DK38493D0 (da) Fremgangsmaade til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
MX9100367A (es) Derivados de heteroarilcetona y procedimiento para su preparacion
DK0388620T3 (da) Fremgangsmåde til fremstilling af o-carboxy-pyridyl- og o-carboxyquinolylimidazolinoner
DK271085D0 (da) N-benzoyl-n'-pyrimidinyloxyphenylurinstofforbindelser og fremgangsmaade til fremstilling af samme
FI932554A7 (fi) Almokalantin kiinteitä annostusmuotoja ja menetelmiä niiden valmistami seksi
FI915518A7 (fi) Menetelmä lääkinnällisesti vaikuttavien heterosyklisesti substituoitujen piperatsinoalkyylibentsoksatsiini- ja -tiatsiiniyhdisteiden valmistamiseksi
IT1185546B (it) Dispositivo e procedimento per la preparazione di pre-calchi per protesi dentarie
DK152087A (da) Indretning og fremgangsmaade til indstilling af tandlaegestol
DK106089D0 (da) Fremgangsmaade til fremstilling af alkansulfonylhalogenider og alkansulfonsyrer

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK